Seborrhea-Like Dermatitis with Psoriasiform Elements
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Seborrheic dermatitis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hyperkeratosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hyperkeratosis, CTCAE
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Seborrhea-Like Dermatitis with Psoriasiform Elements
|
0.600 |
GermlineCausalMutation
|
disease |
ORPHANET |
Seborrhea-like dermatitis with psoriasiform elements caused by a mutation in ZNF750, encoding a putative C2H2 zinc finger protein.
|
16751772 |
2006 |
Seborrhea-Like Dermatitis with Psoriasiform Elements
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Seborrhea-like dermatitis with psoriasiform elements caused by a mutation in ZNF750, encoding a putative C2H2 zinc finger protein.
|
16751772 |
2006 |
Psoriasis
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
This report suggests that ZNF750 mutations could contribute to psoriasis susceptibility.
|
18256691 |
2008 |
Psoriasis
|
0.030 |
GeneticVariation
|
disease |
LHGDN |
This report suggests that ZNF750 mutations could contribute to psoriasis susceptibility.
|
18256691 |
2008 |
Seborrhea-Like Dermatitis with Psoriasiform Elements
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Association analysis identifies ZNF750 regulatory variants in psoriasis.
|
22185198 |
2011 |
Psoriasis
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Using a promoter functional assay in stimulated human primary keratinocytes, we showed that four ZNF750 promoter and 5' UTR variants displayed a 35-55% reduction of ZNF750 promoter activity, consistent with the promoter activity reduction seen in a Mendelian psoriasis family with a ZNF750 promoter variant.
|
22185198 |
2011 |
Psoriasiform eczema
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the ZNF750 promoter and coding regions have been previously associated with Mendelian forms of psoriasis and psoriasiform dermatitis.
|
22185198 |
2011 |
Hay-Wells syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Genomic profiling of a human organotypic model of AEC syndrome reveals ZNF750 as an essential downstream target of mutant TP63.
|
22922031 |
2012 |
Psoriasis
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
We assessed the association of psoriasis and its main clinical phenotypes with common variants of three potential psoriasis susceptibility genes: ZNF750, RPTOR and TRAF31P2.
|
24005976 |
2014 |
Squamous cell carcinoma of esophagus
|
0.060 |
Biomarker
|
disease |
BEFREE |
Functional analyses suggest roles for several genes (CBX4, CBX8, AJUBA, and ZNF750) in ESCC.
|
25839328 |
2015 |
Schizophrenia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
To the best of our knowledge, our study is the first one that links TBCD and ZNF750 mutations to SCZ susceptibility and to the transcript levels in human brain tissues.
|
26728569 |
2016 |
Neoplasms
|
0.060 |
Biomarker
|
group |
BEFREE |
ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma.
|
27819679 |
2017 |
Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
Overexpression of tumor suppressor gene ZNF750 inhibits oral squamous cell carcinoma metastasis.
|
29113187 |
2017 |
Neoplasms
|
0.060 |
Biomarker
|
group |
BEFREE |
ZNF750, an epidermal differentiation regulator, has been suggested to act as a tumor suppressor of esophageal squamous cell carcinoma (ESCC).
|
28558382 |
2017 |
Squamous cell carcinoma of esophagus
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
The aim of the present study was to evaluate the relationship between ZNF750 expression and response to CRT in ESCC.
|
28558382 |
2017 |
Squamous cell carcinoma of esophagus
|
0.060 |
Biomarker
|
disease |
BEFREE |
The present authors previously identified a novel candidate tumor suppressor gene, zinc finger protein 750 (<i>ZNF750</i>), in esophageal squamous cell carcinoma (ESCC) (1).
|
28789412 |
2017 |
Squamous cell carcinoma of esophagus
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Combined analysis from current and previous genomic ESCC studies indicated more frequent ZNF750 mutation in diagnosed cases with LN metastasis than in those without metastasis (14% versus 3.4%, n = 629, P = 1.78 × 10<sup>-5</sup> ).
|
28608921 |
2017 |
Squamous cell carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
Overexpression of tumor suppressor gene ZNF750 inhibits oral squamous cell carcinoma metastasis.
|
29113187 |
2017 |
Squamous cell carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma.
|
27819679 |
2017 |
Malignant Neoplasms
|
0.030 |
GeneticVariation
|
group |
BEFREE |
The Cancer Genome Atlas data further showed that ZNF750 genetic alterations were associated with early disease relapse.
|
28608921 |
2017 |
Primary malignant neoplasm
|
0.030 |
GeneticVariation
|
group |
BEFREE |
The Cancer Genome Atlas data further showed that ZNF750 genetic alterations were associated with early disease relapse.
|
28608921 |
2017 |